Scholars Central

PerspectivePublished 28 Sep 2023

Exploring the Relationship between Celiac Disease and Gut Microbiota

Authors: Patricia Laughlin

Primary Health Care: Open Access

Volume 13 · Issue 9 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Celiac Disease (CD) is a prevalent systemic condition arising from an aberrant immune reaction to gluten consumption, primarily affecting the small intestine. In individuals with a genetic predisposition, CD can be incited by external factors, such as viral infections and disruptions in the gut microbiota, known as dysbiosis. The gut microbiome plays a crucial role in regulating the immune system, and recent discoveries suggest that alterations in the gut microbiome might contribute to various chronic immune disorders, including CD, although the precise mechanisms are still under investigation. Certain bacteria in the gut exhibit epitopes that resemble gliadin, potentially intensifying the host's immune response. Additionally, some bacteria, like Pseudomonas aeruginosa, may collaborate with gluten to initiate and exacerbate intestinal inflammation. The microbiota might also directly influence antigen formation by generating immunogenic or tolerogenic gluten peptides. Furthermore, it could impact intestinal permeability by releasing zonulin, a protein associated with gut barrier function. Based on existing research, changes in the gut microbiome linked to CD typically involve a reduction in beneficial bacteria, including certain antiinflammatory Bifidobacterium species. However, it's worth noting that there is still some debate in this area, as certain studies have not detected significant distinctions in the gut microbiomes of individuals with and without CD. Obtaining a more comprehensive understanding of how the gut microbiome contributes to the development of CD would be highly advantageous for improving both preventive measures and treatment strategies, particularly in cases that are complex or resistant to conventional therapies

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Primary Health Care: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPrimary Health Care: Open Access
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Patricia Laughlin”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels